Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tinea Versicolor | 1 | 2017 | 6 | 0.73 | Why? |
| Myrtus | 1 | 2017 | 4 | 0.73 | Why? |
| Malassezia | 1 | 2017 | 8 | 0.73 | Why? |
| Nontuberculous Mycobacteria | 1 | 2018 | 114 | 0.65 | Why? |
| Epidemiological Monitoring | 2 | 2020 | 3493 | 0.65 | Why? |
| Mycobacterium Infections, Nontuberculous | 2 | 2018 | 167 | 0.62 | Why? |
| Oils, Volatile | 1 | 2017 | 127 | 0.62 | Why? |
| Salmonella Infections, Animal | 1 | 2007 | 18 | 0.35 | Why? |
| Antifungal Agents | 2 | 2017 | 1828 | 0.34 | Why? |
| Salmonella typhimurium | 1 | 2007 | 81 | 0.33 | Why? |
| Zoonoses | 2 | 2020 | 3034 | 0.32 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.31 | Why? |
| Skin | 1 | 2017 | 2096 | 0.29 | Why? |
| Bacterial Proteins | 3 | 2018 | 1318 | 0.28 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.27 | Why? |
| Air Pollution | 1 | 2020 | 3504 | 0.23 | Why? |
| Disease Reservoirs | 2 | 2020 | 1672 | 0.21 | Why? |
| Mozambique | 1 | 2020 | 205 | 0.21 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.20 | Why? |
| Invasive Pulmonary Aspergillosis | 2 | 2017 | 634 | 0.20 | Why? |
| Carbon-Oxygen Ligases | 1 | 2018 | 9 | 0.20 | Why? |
| Mycobacterium smegmatis | 1 | 2018 | 27 | 0.19 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.18 | Why? |
| Genome, Mitochondrial | 1 | 2017 | 14 | 0.18 | Why? |
| Swine | 1 | 2007 | 3352 | 0.17 | Why? |
| Enterococcus faecium | 1 | 2018 | 95 | 0.17 | Why? |
| Human Activities | 1 | 2020 | 293 | 0.17 | Why? |
| Serbia | 1 | 2018 | 227 | 0.17 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2018 | 104 | 0.17 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.17 | Why? |
| Salmonella paratyphi A | 1 | 2016 | 22 | 0.17 | Why? |
| DNA Gyrase | 1 | 2016 | 30 | 0.17 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.17 | Why? |
| Dyspepsia | 1 | 2017 | 60 | 0.17 | Why? |
| Swine Diseases | 1 | 2007 | 1219 | 0.16 | Why? |
| Invasive Fungal Infections | 1 | 2020 | 274 | 0.16 | Why? |
| Salmonella typhi | 1 | 2016 | 98 | 0.16 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.15 | Why? |
| DNA, Mitochondrial | 1 | 2017 | 163 | 0.15 | Why? |
| Italy | 7 | 2021 | 38444 | 0.14 | Why? |
| Genotyping Techniques | 1 | 2017 | 360 | 0.14 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.14 | Why? |
| Biological Evolution | 1 | 2020 | 641 | 0.14 | Why? |
| DNA Mutational Analysis | 1 | 2016 | 581 | 0.13 | Why? |
| Opportunistic Infections | 1 | 2020 | 602 | 0.13 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.13 | Why? |
| Helicobacter pylori | 1 | 2017 | 262 | 0.13 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.13 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.13 | Why? |
| China | 4 | 2020 | 50654 | 0.12 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2016 | 669 | 0.12 | Why? |
| Microbial Sensitivity Tests | 2 | 2017 | 2886 | 0.11 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.11 | Why? |
| Respiratory Tract Infections | 1 | 2012 | 6817 | 0.11 | Why? |
| Camelus | 1 | 2020 | 1425 | 0.11 | Why? |
| Mucormycosis | 1 | 2020 | 832 | 0.11 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Lung Diseases, Obstructive | 1 | 2010 | 46 | 0.10 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.10 | Why? |
| Pneumothorax | 1 | 2017 | 758 | 0.09 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.09 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.09 | Why? |
| Affective Symptoms | 1 | 2010 | 160 | 0.09 | Why? |
| Infant | 2 | 2020 | 30274 | 0.08 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.08 | Why? |
| Plant Extracts | 1 | 2017 | 1514 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.08 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.07 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.07 | Why? |
| Middle Aged | 9 | 2020 | 270681 | 0.07 | Why? |
| Clinical Competence | 1 | 2020 | 3263 | 0.07 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.07 | Why? |
| Aged | 7 | 2020 | 215776 | 0.07 | Why? |
| Cluster Analysis | 1 | 2012 | 3001 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.07 | Why? |
| Respiration Disorders | 1 | 2010 | 526 | 0.07 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.06 | Why? |
| Humans | 19 | 2021 | 930598 | 0.06 | Why? |
| Fatal Outcome | 1 | 2012 | 3438 | 0.06 | Why? |
| Vietnam | 2 | 2018 | 1665 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Male | 8 | 2020 | 367725 | 0.06 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.06 | Why? |
| Saudi Arabia | 1 | 2012 | 4423 | 0.06 | Why? |
| Gene Amplification | 1 | 2021 | 85 | 0.06 | Why? |
| Physical Therapy Modalities | 1 | 2010 | 1090 | 0.05 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Child | 2 | 2020 | 70012 | 0.05 | Why? |
| Female | 8 | 2020 | 380317 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Evolution, Molecular | 3 | 2018 | 3691 | 0.05 | Why? |
| Operon | 1 | 2018 | 12 | 0.05 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.05 | Why? |
| Microorganisms, Genetically-Modified | 1 | 2018 | 19 | 0.05 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.05 | Why? |
| Chromosomes, Bacterial | 1 | 2018 | 18 | 0.05 | Why? |
| Animals | 4 | 2020 | 78931 | 0.05 | Why? |
| Nasal Obstruction | 1 | 2020 | 131 | 0.05 | Why? |
| Recovery of Function | 1 | 2010 | 2461 | 0.05 | Why? |
| Sequence Analysis, Protein | 1 | 2020 | 309 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Bacterial Adhesion | 1 | 2018 | 69 | 0.05 | Why? |
| Gene Transfer, Horizontal | 1 | 2018 | 64 | 0.05 | Why? |
| DNA Transposable Elements | 1 | 2018 | 91 | 0.05 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2007 | 1115 | 0.05 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.04 | Why? |
| Adult | 4 | 2020 | 244371 | 0.04 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.04 | Why? |
| Phylogeny | 3 | 2017 | 13341 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.04 | Why? |
| DNA, Ancient | 1 | 2017 | 15 | 0.04 | Why? |
| Drug Resistance, Bacterial | 2 | 2018 | 1414 | 0.04 | Why? |
| Islands | 1 | 2017 | 81 | 0.04 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.04 | Why? |
| Genetics, Population | 1 | 2017 | 162 | 0.04 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.04 | Why? |
| Teicoplanin | 1 | 2018 | 191 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.04 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.04 | Why? |
| Immunocompetence | 1 | 2017 | 280 | 0.04 | Why? |
| Voriconazole | 1 | 2017 | 206 | 0.04 | Why? |
| Fluoroquinolones | 1 | 2016 | 235 | 0.04 | Why? |
| Plasmids | 1 | 2018 | 840 | 0.04 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.03 | Why? |
| Aspergillus fumigatus | 1 | 2017 | 239 | 0.03 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.03 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.03 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.03 | Why? |
| Haplotypes | 1 | 2017 | 853 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.03 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Mutation, Missense | 1 | 2016 | 863 | 0.03 | Why? |
| Anti-Bacterial Agents | 2 | 2016 | 10083 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.03 | Why? |
| Demography | 1 | 2017 | 1660 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Brazil | 1 | 2007 | 12582 | 0.02 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.02 | Why? |
| Protein Domains | 1 | 2018 | 6563 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| RNA, Viral | 1 | 2012 | 32276 | 0.02 | Why? |
| Exercise Test | 1 | 2010 | 911 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Travel | 1 | 2020 | 7220 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.01 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.01 | Why? |
| Dyspnea | 1 | 2010 | 3847 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Prevalence | 1 | 2010 | 25773 | 0.01 | Why? |
Rubino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(73)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_